Seroprevalence of SARS-CoV-2 antibodies among Japanese healthcare workers from 2020 to 2022 as assayed by two commercial kits
Abstract Antibody tests are used as surveillance tools for informing health policy making. However, results may vary by type of antibody assay and timing of sample collection following infection. Long-term longitudinal cohort studies on antibody assay seropositivity have remained limited, especially...
Main Authors: | Yan Yan, Kaori Saito, Toshio Naito, Kanami Ito, Shuko Nojiri, Yuki Horiuchi, Gautam A. Deshpande, Hirohide Yokokawa, Yoko Tabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-024-53656-2 |
Similar Items
-
SARS-CoV-2 seroprevalence among healthcare workers in a highly vaccinated Japanese medical center from 2020–2023
by: Yan Yan, et al.
Published: (2024-12-01) -
Increased SARS-CoV-2 seroprevalence and spread of infection without awareness among healthcare workers through 2020–2022 in a Japanese medical center
by: Rie Kanamori, et al.
Published: (2023-03-01) -
Antibody response and seroprevalence in healthcare workers after the BNT162b2 vaccination in a University Hospital at Tokyo
by: Gene Igawa, et al.
Published: (2022-05-01) -
SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge
by: Yoshie Hosaka, et al.
Published: (2023-02-01) -
Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo
by: Hiroshi Fukuda, et al.
Published: (2021-08-01)